Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct:99:107647.
doi: 10.1016/j.ijscr.2022.107647. Epub 2022 Sep 13.

Huge retroperitoneal liposarcoma encasing right kidney: A case report from Nepal

Affiliations
Case Reports

Huge retroperitoneal liposarcoma encasing right kidney: A case report from Nepal

Anil Suryabanshi et al. Int J Surg Case Rep. 2022 Oct.

Abstract

Introduction and importance: Retroperitoneal liposarcoma is a rare entity originating from adipocytes. Before showing any symptoms, it can grow hugely and envelop nearby structures. Surgery is the optimum course of treatment, however, well-differentiated liposarcomas make it challenging to discern between malignant and normal adipocytes during surgery.

Case presentation: We report a case of a 62-year-old male referred to evaluate his abdominal distention presented for four years. Recently he had developed loin pain for six months. A computerized tomography scan showed extensive tumor encompassing the right kidney and ureter, colon, and duodenum, however, exploratory laparotomy revealed free colon and duodenum. Complete resection of the mass with a right nephrectomy was performed. Subsequently, a histopathological assessment of the resected specimen confirmed the diagnosis of well-differentiated liposarcoma. Adjuvant chemotherapy was initiated as the tumor was a high-risk sarcoma but local recurrence was observed after 2 years despite surgery and chemotherapy.

Clinical discussion: Imaging modalities are the mainstay of preoperative diagnosis. Preferably, surgical resection with a tumor-free margin is recommended to avoid tumor recurrence which remains the primary challenge. This, along with the grade of the tumor, multifocal disease, and invasion of adjacent structure dictate the prognosis of the disease. Adjuvant chemotherapy and radiotherapy are not regarded as standard therapies for resectable retroperitoneal liposarcoma, although further research is still needed to determine their value in the case of high-risk sarcoma.

Conclusion: Retroperitoneal liposarcoma has the potential to present as huge asymptomatic masses which with an added predilection for recurrence poses a huge challenge to any surgeon.

Keywords: Case report; Liposarcoma; Nephrectomy; Retroperitoneum; Surgery.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest All the authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
CECT showing huge retroperitoneal liposarcoma (white arrow) with high-fat attenuation and septation. The tumor is encasing the right kidney (blue arrow) and displaces the viscera (yellow arrow). (A-axial, B-sagittal, C-coronal view). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2
Fig. 2
Intra-operative view showing tumor in -situ (white arrow).
Fig. 3
Fig. 3
Gross picture showing huge tumor including kidney (yellow arrow). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 4
Fig. 4
Hematoxylin and eosin stain (magnification ×100) showing atypical adipocytes with eccentric nuclei.
Fig. 5
Fig. 5
CECT of abdomen and pelvis showing heterogeneously enhancing soft tissue lesion (white arrow) in the right side of abdominopelvic cavity abutting and displacing adjacent bowel loops and urinary bladder.

References

    1. Brennan M.F., Antonescu C.R., Maki R.G. Management of soft tissue. Sarcoma. 2013 doi: 10.1007/978-1-4614-5004-7. - DOI
    1. Vijay A., Ram L. Retroperitoneal liposarcoma: a comprehensive review. Am. J. Clin. Oncol. Cancer Clin. Trials. 2015;38 doi: 10.1097/COC.0b013e31829b5667. - DOI - PubMed
    1. Russell W.O., Cohen J., Enzinger F., Hajdu S.I., Heise H., Martin R.G., Meissner W., Miller W.T., Schmitz R.L., Suit H.D. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977;40 doi: 10.1002/1097-0142(197710)40:4<1562::AID-CNCR2820400428>3.0.CO;2-6. - DOI - PubMed
    1. Xiao J., Liu J., Chen M., Liu W., He X. Diagnosis and prognosis of retroperitoneal liposarcoma: a single asian center cohort of 57 cases. J. Oncol. 2021;2021 doi: 10.1155/2021/7594027. - DOI - PMC - PubMed
    1. Messiou C., Moskovic E., Vanel D., Morosi C., Benchimol R., Strauss D., Miah A., Douis H., van Houdt W., Bonvalot S. Primary retroperitoneal soft tissue sarcoma: imaging appearances, pitfalls and diagnostic algorithm. Eur. J. Surg. Oncol. 2017;43:1191–1198. doi: 10.1016/J.EJSO.2016.10.032. - DOI - PubMed

Publication types